Compare Bakrieland Development Tbk. (ELTY) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bakrieland Development Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Bakrieland Development Tbk. trades at Rp22 (market cap 1T, 28.75M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 11.2× Bakrieland Development Tbk.'s market cap, and Bakrieland Development Tbk. is more actively traded (28.75M versus 613K). Which is the better fit depends on your goals.
| ELTY | TSPC | |
|---|---|---|
Market Cap | 1T | 11.18T |
Volume | 28.75M | 613K |
Lot | 287.49K | 6.13K |
Turnover | 638.29M | 1.54B |
Average Price | 22.2 | 2,511.52 |
Value | 638.29M | 1.54B |
Indicative Equilibrium Price | 22 | 2,520 |
Indicative Equilibrium Volume | 65.62K | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bakrieland Development Tbk.
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Read more on ELTY →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
